-
Sony Research Award Program: Focused Research Award
The Sony Research Award Program provides funding for cutting-edge academic research and helps build a collaborative relationship between faculty and Sony researchers. -
Sony Research Award Program: Faculty Innovation Award
The Sony Research Award Program provides funding for cutting-edge academic research and helps build a collaborative relationship between faculty and Sony researchers. -
Merck’s Discovery Biologics
Under the SEEDS program (Scientific Engagement and Emerging Discovery Science) Merck’s Discovery Biologics looks to fund research projects on the below subject areas. -
Strategic Partnership, 2025
An initiative to work together with academic institutions to de-risk innovation and bridge the translational gap of early-stage research. -
Seeking Vaccine Candidates with Cross-protection Against Canine Leptospira
An animal health company is seeking novel vaccine candidates to protect against canine leptospirosis and/or leptospiruria. -
Seeking Proteases as Inhibitory Targets for Disease Treatment
Daiichi Sankyo is seeking research related to the identification and mechanistic characterization of extracellular proteases whose inhibition suppresses disease onset or progression. -
Drug Delivery Platforms: Novel BBB-penetrating Systems, Ocular Eye-drop Systems, and Tumor Tissue-targeted Intracellular Approaches
Daiichi Sankyo is seeking novel drug delivery platform opportunities in three strategic areas: CNS drug delivery, ocular delivery systems, and tumor tissue-targeted delivery technologies. -
CSL Research Acceleration Initiative
CSL's Research Acceleration Initiative supports early-stage biotechs and research organizations to fast-track the discovery of groundbreaking biotherapies with non-dilutive funding and access to global industry capabilities. -
High Throughput Screening Assays to Map Macrocyclic Peptide Permeability and Stability Properties
AstraZeneca is seeking screening assays or predictive models relevant to oral bioavailability and cell permeability of macrocyclic peptides to help map and model the property space required for oral and cell-permeable macrocyclic therapeutics. -
AI/ML-ready Datasets for Peptide Permeability & Oral Bioavailability or Macrocyclic Peptide Screening Libraries
AstraZeneca is seeking datasets or physical/virtual libraries of macrocyclic peptides that can help map and model the property space required for oral and cell permeable macrocyclic peptides